BeStock  
Stocks › Biotechnology › NTLA

Intellia Therapeutics NTLA

US equityMarket cap rank #2922BiotechnologyGene Editing
$10.00 +$0.48 (+5.04%)
Market closed · Nov 20, 8:10 pm ET · Last extended-hours $10.00 +0.01%
Open$9.34
Prev close$9.52
Day range$9.30 – $10.40
Volume15.19M
Market cap$1.40B
P/E (TTM)–
Dividend yield–

Ownership & positioning

Who holds it, who is betting against it, and where the big money is moving

Institutional ownership103.7%-0.91 pts vs. prior quarter
Institutions holding382-10 vs. prior quarter
Insider trades (recent)31 buys / 19 sellsNet buying
ARK fund activity+37,586 sh1 recent transactions · last 26 Oct 2026
Short interest31.66% of floatDays to cover 11.1 · as of 30 Oct 2026
Short-sale volume share27.8%5-day average of daily volume

Short-sale volume as % of daily volume

13%22%31%41%Oct '26Oct '26Nov '26

Large-order net flow, last 20 sessions

Net of large-order buying minus selling, in USD. Over this window: −$8.57M (7 inflow days, 13 outflow days).

Net flow by order size, last 20 sessions

−$4.5MSuper−$4.1MBig−$6.2MMid+$557.4KSmall

Super/Big orders approximate institutional-size trades; Mid/Small approximate retail-size trades. Net buy minus sell value in each bucket, summed over the window.

The five largest holders on file together own 38.2% of shares outstanding.

Largest holders

  • BlackRock11.42%
  • ARK Investment Management LLC11.35%
  • State Street Global Advisors5.56%
  • Vanguard Portfolio Management, LLC5.26%
  • D. E. Shaw & Co., L.P.4.59%
  • Vanguard Capital Management, LLC4.30%
  • Two Sigma Investments, LP3.73%
  • FMR3.34%

By investor type

  • Mutual Fund72.29%
  • Hedge Fund16.46%
  • Public Company7.92%
  • VC/PE Fund3.48%
  • Private Company2.73%
  • Individual/Insider1.57%
  • Government Pension Fund0.45%
  • Insurance Company0.26%

Reported short interest has fallen from 32.03% to 31.66% of float over the last 6 biweekly reports (14 Aug 2026 to 30 Oct 2026).

Recent institutional activity

HolderTypePeriodShare changeNew stake
Federated Hermes, Inc. Mutual Fund 2026/Q3 +850,265 1.1%
Amova Asset Management Mutual Fund 2026/Q3 +708,094 2.6%
Sumitomo Mitsui Trust Asset Management Mutual Fund 2026/Q3 +708,094 2.6%
BlackRock Mutual Fund 2026/Q3 +626,400 11.4%
Connor, Clark & Lunn Investment Management Ltd. Mutual Fund 2026/Q3 +486,067 1.0%
Contrarius Investment Management Ltd. Mutual Fund 2026/Q3 +476,991 1.7%
First Trust Advisors L.P. Mutual Fund 2026/Q3 +374,356 0.5%
Nuveen Asset Management LLC Insurance Company 2026/Q3 +357,651 0.3%
RA Capital Management, L.P. VC/PE Fund 2026/Q3 +4,526,926 3.2%
BlackRock Mutual Fund 2026/Q3 +3,253,217 11.0%
FMR Mutual Fund 2026/Q3 +2,705,884 3.4%
ARK Investment Management LLC Mutual Fund 2026/Q3 +2,366,437 12.0%
State Street Global Advisors Mutual Fund 2026/Q3 +2,312,311 6.6%
Arrowstreet Capital, Limited Partnership Mutual Fund 2026/Q3 +1,883,517 2.3%
Renaissance Technologies Corp. Hedge Fund 2026/Q3 +1,400,004 1.0%

Institutional buy/sell activity by reporting period, largest moves first.

Insider transactions

DateInsiderTitleTransactionSharesPriceHeld after
1 Nov 2026 John Leonard Chief Executive Officer Automatic Disposition -9,000 $11.99 1,196,479
25 Oct 2026 Jing Marantz EVP & Chief Medical Officer Other Acquisition +199,822 – 199,822
25 Oct 2026 Jing Marantz EVP & Chief Medical Officer Other Derivative Acquisition +275,061 $11.26 275,061
1 Oct 2026 Michael Dube Vice President Open Market Disposition -1,864 $12.43 65,022
20 Aug 2026 John Leonard Chief Executive Officer Automatic Disposition -22,675 $13.00 1,205,479
19 Aug 2026 John Leonard Chief Executive Officer Intent to Sell (Form 144) -22,675 $12.95 –
21 Jul 2026 Edward Dulac Chief Financial Officer Open Market Disposition -8,111 $11.25 148,175
1 Jul 2026 Edward Dulac Chief Financial Officer Automatic Disposition -4,677 $18.00 156,286
30 Jun 2026 Michael Dube Vice President Open Market Disposition -2,641 $16.78 66,886
8 Jun 2026 Fred Cohen Independent Director Other Acquisition +9,200 – 17,200
8 Jun 2026 Fred Cohen Independent Director Other Derivative Acquisition +13,300 $12.89 13,300
8 Jun 2026 Franciscus A. G. Verwiel Independent Chairperson Other Acquisition +9,200 – 17,200
8 Jun 2026 Franciscus A. G. Verwiel Independent Chairperson Other Derivative Acquisition +13,300 $12.89 13,300
8 Jun 2026 William Chase Independent Director Other Acquisition +9,200 – 143,893
8 Jun 2026 William Chase Independent Director Other Derivative Acquisition +13,300 $12.89 13,300
8 Jun 2026 Brian Goff Independent Director Other Acquisition +9,200 – 17,200
8 Jun 2026 Brian Goff Independent Director Other Derivative Acquisition +13,300 $12.89 13,300
8 Jun 2026 Jesse Goodman Independent Director Other Acquisition +9,200 – 17,200
8 Jun 2026 Jesse Goodman Independent Director Other Derivative Acquisition +13,300 $12.89 13,300
8 Jun 2026 Georgia Keresty Independent Director Other Acquisition +9,200 – 17,200

From Form 4/Form 144 filings. Negative share counts are disposals (sales, gifts, or shares withheld for taxes); positive are acquisitions.

Short interest, by report

Report dateShares short% of floatDays to cover
30 Oct 2026 44,361,762 31.7% 11.1
15 Oct 2026 44,435,219 31.7% 6.5
30 Sep 2026 45,110,513 32.2% 9.5
15 Sep 2026 46,681,609 33.3% 14.1
31 Aug 2026 43,928,014 31.3% 12.9
14 Aug 2026 44,880,339 32.0% 13.2

Discussion

No comments yet — be the first to weigh in on NTLA.

Sign in to join the discussion.

Scroll to Top